Research & Development
Browse our research documents and publications, view our product pipeline and learn more about our research partners.
Reports, publications, and papers
Browse relevant documents to see the insights and thought leadership that we’ve spear headed over the years.
Press Release: Calpro X Ampersand Health
Oct 2021 London - Today, Ampersand Health and Calpro AS, a Svar Life Science company, have announced a new partnership integrating the CalproSmart™ Self-Test...
Patient Voices Podcast Episode 3
As part of our Patient Voices podcast series, we spoke to Teresa Shakespeare-Smith and Sally Dickinson.
Patient Voices Podcast Episode 2
As part of our podcast series, we spoke to Heather Savage and Anisha Gangotra. The conversation is captured in this blog.
Patient Voices Podcast Episode 1
We want to champion the experiences and opinions of the most important members of the healthcare ecosystem, patients. This week, we speak to Katy.
Patient Voices Podcast Launch – August 2021
We've launched Ampersand's Patient Voices Podcast: Experiences and expertise from the Ampersand community.
My IBD Care Service Evaluation at King’s College Hospital & The Royal London
In 2019, we were awarded an InnovateUK grant, which has enabled us to conduct this study, comprising over 300 adults across two large London centres (Barts...
On Demand Webinar – Digital Therapeutics: Transforming Patient Experience and Quality of Life
Listen in to our conversations with leading experts in healthtech, digital therapeutics, pharma and clinical care to hear more about how healthtech and pharma...
Clinician-Patient Communication: Time for a Wake-up Call?
In light of the launch of My Arthritis, Ampersand Health hosted an industry roundtable to discuss the future of clinician-patient communication.
My Arthritis App: Q&A for Clinicians
We answer common questions that clinicians may have around the application and benefits of our My Arthritis app.
Ampersand Health launches Whitepaper: Designing Digital Behaviour Change Interventions
The paper uncovers the evidence behind our digital therapeutics approach to managing immune-mediated inflammatory conditions (IMIDs) such as Inflammatory Bowel...
Our HealthSuite can help manage a range of inflammatory conditions
Our research and development focuses on the full breadth of inflammatory and immuno-mediated conditions, enabling us to build an exciting roadmap of digital medicines.
Currently, an observational trial is underway that is looking into the effectiveness of using a mobile application to collect Patient Reported Outcome data of those receiving treatment for Neuroendocrine Tumours.
This study is being conducted by King's College Hospital, along with a national charity and a major pharmaceutical company. Individuals who live with Neuroendocrine Tumours live a lower quality of life due to their condition. We are exploring the role digital therapeutics could play to alleviate treatment burden and improve clinical coordination to help patients gain a better quality of life.
Sickle Cell Disease
A leading NHS Trust and The Health Foundation are researching how our My Blood app can improve the process of collecting information from patients to avoid unnecessary trips to the hospital.
The My Blood app helps patients recieve remote care and could alleviate treatment burden, leading to benefits for both clinicians and patients.
Our app content is co-created with leading experts from 2 London hospitals.
NHS - Barts Health & King's College Hospital
We are partnered with the NHS, the world’s largest public health provider.
Our partnership with the NHS has allowed us to perform significant research and gain invaluable insights into the conditions that we focus on.
We have partnered with national charities, such as Crohn’s and Colitis UK.
Our partnerships with national charities allow us to gain important insights into the experiences of the communities we work with.
Our platform has been assessed and approved by NICE, The National Institute for Health and Care Excellence.
Our innovation has been funded by competitive grants from Innovate UK.
Our platform is regulated by the Medicines and Healthcare Products Regulatory Agency.
Our app received the top rating by ORCHA, who are world leaders in health app evaluations.